Skip to content
6-K

Foreign Interim / Material

Gracell Biotechnologies Inc.

0001104659-23-091460

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2023 · Jun 30, 2023 339.95M sh
Shares Diluted Q2 2023 · Jun 30, 2022 338.24M sh
Capex Q2 2023 · Jun 30, 2023 $1.38M
Capex Q2 2023 · Jun 30, 2023 ¥9.97M
Capex Q2 2023 · Jun 30, 2022 ¥24.6M
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$38.86M
Operating Cash Flow Q2 2023 · Jun 30, 2023 −¥281.81M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −¥204.71M
Long Term Debt Q2 2023 · Jun 30, 2023 $5.51M
Long Term Debt Q2 2023 · Jun 30, 2023 ¥39.96M
Long Term Debt Q2 2023 · Dec 31, 2022 ¥46.51M
Short Term Debt Q2 2023 · Jun 30, 2023 $14.21M
Short Term Debt Q2 2023 · Jun 30, 2023 ¥103M
Short Term Debt Q2 2023 · Dec 31, 2022 ¥112.44M
Short Term Investments Q2 2023 · Jun 30, 2023 $493K
Short Term Investments Q2 2023 · Jun 30, 2023 ¥3.57M
Short Term Investments Q2 2023 · Dec 31, 2022 ¥3.56M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $163.34M
Cash And Equivalents Q2 2023 · Jun 30, 2023 ¥1.18B
Cash And Equivalents Q2 2023 · Dec 31, 2022 ¥1.45B
Stockholders Equity Q2 2023 · Jun 30, 2023 $156.76M
Stockholders Equity Q2 2023 · Jun 30, 2023 ¥1.14B
Stockholders Equity Q2 2023 · Dec 31, 2022 ¥1.38B
Stockholders Equity Q2 2023 · Jun 30, 2022 ¥1.61B
Stockholders Equity Q2 2023 · Dec 31, 2021 ¥1.83B
Current Liabilities Q2 2023 · Jun 30, 2023 $26.73M
Current Liabilities Q2 2023 · Jun 30, 2023 ¥193.82M
Current Liabilities Q2 2023 · Dec 31, 2022 ¥220.64M
Total Liabilities Q2 2023 · Jun 30, 2023 $33.26M
Total Liabilities Q2 2023 · Jun 30, 2023 ¥241.17M
Total Liabilities Q2 2023 · Dec 31, 2022 ¥280.51M
Current Assets Q2 2023 · Jun 30, 2023 $172.03M
Current Assets Q2 2023 · Jun 30, 2023 ¥1.25B
Current Assets Q2 2023 · Dec 31, 2022 ¥1.5B
Total Assets Q2 2023 · Jun 30, 2023 $190.02M
Total Assets Q2 2023 · Jun 30, 2023 ¥1.38B
Total Assets Q2 2023 · Dec 31, 2022 ¥1.66B
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.12
Eps Diluted Q2 2023 · Jun 30, 2023 −¥0.88
Eps Diluted restated Q2 2023 · Jun 30, 2022 −¥0.90
Eps Basic Q2 2023 · Jun 30, 2023 −$0.12
Eps Basic Q2 2023 · Jun 30, 2023 −¥0.88
Eps Basic restated Q2 2023 · Jun 30, 2022 −¥0.90
Sga Expense Q2 2023 · Jun 30, 2023 $9.16M
Sga Expense Q2 2023 · Jun 30, 2023 ¥66.44M
Sga Expense Q2 2023 · Jun 30, 2022 ¥66.66M
Rd Expense Q2 2023 · Jun 30, 2023 $33.28M
Rd Expense Q2 2023 · Jun 30, 2023 ¥241.31M
Rd Expense Q2 2023 · Jun 30, 2022 ¥238.9M
Net Income Q2 2023 · Jun 30, 2023 −$41.19M
Net Income Q2 2023 · Jun 30, 2023 −¥298.66M
Net Income Q2 2023 · Jun 30, 2022 −¥304.89M
Operating Income Q2 2023 · Jun 30, 2023 −$42.44M
Operating Income Q2 2023 · Jun 30, 2023 −¥307.75M
Operating Income Q2 2023 · Jun 30, 2022 −¥305.55M